Log In
BCIQ
Print this Print this
 

Spleen tyrosine kinase (SYK)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Spleen tyrosine kinase (SYK)

BCIQ
Print ChartPrint this
0 0 0 1 0 0 1 0 0 0 2 0 0 0 0 1 0 0 0 0 2 2 1 1 0 5 3 0 0 1
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase III
Autoimmune

5

3

0

0

1

Cancer

2

2

1

1

0

Inflammation

1

0

0

0

0

Ophthalmic

2

0

0

0

0

Renal

0

1

0

0

0

Transplant

0

0

0

1

0




 Products Targeting Spleen tyrosine kinase (SYK)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$673.5M

$136.0M

$1,708.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today